Analysts think NMTC stock price could increase by 139%
May 11, 2025, 11:25 AM
-7.86%
What does NMTC do
NeuroOne Medical Technologies, headquartered in Eden Prairie, Minnesota, develops thin film electrode technology for neurodiagnostic and treatment solutions, focusing on conditions like epilepsy and chronic pain. The company went public on November 9, 2012, and employs 16 people.
3 analysts think NMTC stock price will increase by 138.78%. The current median analyst target is $1.48 compared to a current stock price of $0.62. The lowest analysts target is $1.46 and the highest analyst target is $1.52.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
